The First Longevity Board: How Insilico Medicine Is Using AI to Target the Biology of Aging Itself
Insilico Medicine has formed the industry’s first Longevity Board, chaired by Eli Lilly’s Group VP of Molecular Discovery and featuring Nobel laureate Michael Levitt. Inside the AI strategy, dual-purpose targets,…
